NO20043735L - Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene - Google Patents

Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene

Info

Publication number
NO20043735L
NO20043735L NO20043735A NO20043735A NO20043735L NO 20043735 L NO20043735 L NO 20043735L NO 20043735 A NO20043735 A NO 20043735A NO 20043735 A NO20043735 A NO 20043735A NO 20043735 L NO20043735 L NO 20043735L
Authority
NO
Norway
Prior art keywords
acylaminoalkenylenamide
intestines
derivatives
motility disorders
functional motility
Prior art date
Application number
NO20043735A
Other languages
English (en)
Norwegian (no)
Inventor
John R Fozard
Hans-Juergen Pfannkuche
Weber Eckhard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20043735L publication Critical patent/NO20043735L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
NO20043735A 2002-02-08 2004-09-07 Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene NO20043735L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
PCT/EP2003/001227 WO2003066062A1 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Publications (1)

Publication Number Publication Date
NO20043735L true NO20043735L (no) 2004-09-07

Family

ID=9930743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043735A NO20043735L (no) 2002-02-08 2004-09-07 Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene

Country Status (18)

Country Link
US (2) US20050203164A1 (https=)
EP (2) EP1476167A1 (https=)
JP (2) JP2005516994A (https=)
KR (2) KR20100100994A (https=)
CN (1) CN1301714C (https=)
AU (1) AU2003244446B2 (https=)
BR (1) BR0307479A (https=)
CA (1) CA2471964A1 (https=)
GB (1) GB0203061D0 (https=)
IL (2) IL162816A0 (https=)
MX (1) MXPA04007640A (https=)
NO (1) NO20043735L (https=)
NZ (1) NZ534231A (https=)
PL (1) PL370255A1 (https=)
RU (1) RU2353356C2 (https=)
TW (1) TWI330177B (https=)
WO (1) WO2003066062A1 (https=)
ZA (1) ZA200404960B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
EP1686985A2 (en) 2003-10-27 2006-08-09 Novartis AG Use of neurokinin antagonists in the treatment of urinary incontinence
CN101568331A (zh) 2006-09-08 2009-10-28 奥尔制药有限公司 减少或缓解消化道炎症的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
MX9706394A (es) * 1995-02-22 1997-11-29 Novartis Ag Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina, especialmente neuroquinina-1.
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
PL191496B1 (pl) * 1997-07-02 2006-05-31 Merck & Co Inc Odmiana polimorficzna 2-(R)-{1-(R) -[3,5-bis(trifluorometylo)-fenylo]etoksy} -3-(S)-(4-fluoro) fenylo-4-[3-(5-okso-1H,4H-1,2,4-triazolo)metylo] morfoliny, sposób jej wytwarzania, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
US20040058914A1 (en) * 2000-12-22 2004-03-25 Takayuki Doi Combination drugs
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
KR20040081492A (ko) 2004-09-21
US20070293473A1 (en) 2007-12-20
GB0203061D0 (en) 2002-03-27
EP2216025A3 (en) 2010-11-10
JP2005516994A (ja) 2005-06-09
EP2216025A2 (en) 2010-08-11
KR20100100994A (ko) 2010-09-15
ZA200404960B (en) 2006-05-31
TWI330177B (en) 2010-09-11
PL370255A1 (en) 2005-05-16
EP1476167A1 (en) 2004-11-17
MXPA04007640A (es) 2004-11-10
JP2010241835A (ja) 2010-10-28
IL162816A (en) 2010-11-30
RU2004127132A (ru) 2005-06-10
US20050203164A1 (en) 2005-09-15
RU2353356C2 (ru) 2009-04-27
WO2003066062A1 (en) 2003-08-14
AU2003244446A1 (en) 2003-09-02
TW200302818A (en) 2003-08-16
AU2003244446B2 (en) 2006-08-10
CA2471964A1 (en) 2003-08-14
CN1301714C (zh) 2007-02-28
HK1077749A1 (en) 2006-02-24
BR0307479A (pt) 2004-12-07
IL162816A0 (en) 2005-11-20
NZ534231A (en) 2007-02-23
CN1627947A (zh) 2005-06-15

Similar Documents

Publication Publication Date Title
DE60328671D1 (de) Neue aminobenzamidderivate
ATE460418T1 (de) Heterocyclocarboxamidderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK1594840T3 (da) Piperidin-benzensulfonamid-derivater
DE60324296D1 (de) Kondensierte azolpyrimidinderivate
EP1552547A4 (en) IN-SITU TRAINING OF METALLISOLATOR METAL CAPACITORS CROSS-REFERENCE TO RELATED APPLICATIONS
ATE352550T1 (de) Chinazolinderivate
DK1682493T3 (da) Amidoacetonitrilderivater
NO20043696L (no) Gamma-sekretaseinhibitorer
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
DK1606277T3 (da) Imidazol-4-yl-ethynyl-pyridinderivater
IS8352A (is) Ný rópínírólsamsetning
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DE60307512D1 (de) 3h-chinazoline -4-on derivaten
BRPI0312048A2 (pt) conjunto para redução de dobras
ATE354365T1 (de) N-thiazol-2-yl-benzamid-derivate
DK1706373T3 (da) Amidoacetonitrilderivater
DE60321998D1 (de) Optometrisches Instrument
IS8045A (is) Púrín-6-ón-afleiður
NO20043735L (no) Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
HUP0203929D0 (en) New use of substituted alkyl-piridazinone derivatives
FR2856260B1 (fr) Cadre de lit
FR2858206B1 (fr) Extensiometre de la peau
DOP2003000677A (es) Derivados benzofurado y benzotiofeno utiles en el tratamiento de desordenes hiper-proliferativos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application